Innovative rapid gene methylation analysis of surgical margin tissues in head and neck cancer
- PMID: 24671639
- PMCID: PMC4834866
- DOI: 10.1245/s10434-014-3661-2
Innovative rapid gene methylation analysis of surgical margin tissues in head and neck cancer
Abstract
Background: Securing the negative surgical margin is the first step in surgical cancer treatment. However, tumor recurrence sometimes occurs even with histologically negative surgical margins. To detect minimal residual cancer cells in the deep margin intraoperatively, a time-efficient molecular approach is required.
Methods: We established an innovative rapid quantitative methylation PCR (QMSP) assay, which consists of substantially time-minimized DNA extraction, bisulfite treatment, and QMSP assays. To demonstrate the feasibility of this procedure, 10 serial surgical specimens of primary head and neck squamous cell carcinoma (HNSCC) were evaluated by both rapid and conventional QMSP. Two frequently methylated genes in head and neck cancer, homeobox A9 (HOXA9) and endothelin receptor type B (EDNRB) were analyzed in 10 HNSCCs and surgical margin tissues, as well as normal muscle and oral mucosa samples.
Results: The product quality of DNA extraction and bisulfite treatment using the time-saving procedure was comparable to the conventional procedure. In the QMSP assay, target gene methylation and reference gene methylation were equally detected by both the rapid and conventional method. Finally, relative results of rapid and conventional QMSP were quite similar to each other in tumors, margins, and normal tissues. The average total time required for the rapid QMSP procedure was less than 3 h and could be accomplished by a single person.
Conclusion: From the viewpoint of accuracy, cost, and time consumption, the innovative rapid QMSP maintains highly sensitive methylation detection accomplished within the time frame of a major ablative and reconstructive procedure.
Figures



Similar articles
-
Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.Cancer. 2015 Jun 15;121(12):1957-65. doi: 10.1002/cncr.29303. Epub 2015 Mar 13. Cancer. 2015. PMID: 25773145 Free PMC article.
-
Intraoperative molecular margin analysis in head and neck cancer.Arch Otolaryngol Head Neck Surg. 2004 Jan;130(1):39-44. doi: 10.1001/archotol.130.1.39. Arch Otolaryngol Head Neck Surg. 2004. PMID: 14732766
-
Paired box 5 methylation detection by droplet digital PCR for ultra-sensitive deep surgical margins analysis of head and neck squamous cell carcinoma.Cancer Prev Res (Phila). 2015 Nov;8(11):1017-26. doi: 10.1158/1940-6207.CAPR-15-0180. Epub 2015 Aug 24. Cancer Prev Res (Phila). 2015. PMID: 26304463 Free PMC article.
-
Molecular diagnosis of head and neck cancer.Recent Results Cancer Res. 2000;157:90-106. doi: 10.1007/978-3-642-57151-0_8. Recent Results Cancer Res. 2000. PMID: 10857164 Review.
-
DNA methylation in tumour and normal mucosal tissue of head and neck squamous cell carcinoma (HNSCC) patients: new diagnostic approaches and treatment.Med Oncol. 2013;30(3):654. doi: 10.1007/s12032-013-0654-0. Epub 2013 Jul 4. Med Oncol. 2013. PMID: 23824644 Review.
Cited by
-
Outlier Analysis Defines Zinc Finger Gene Family DNA Methylation in Tumors and Saliva of Head and Neck Cancer Patients.PLoS One. 2015 Nov 6;10(11):e0142148. doi: 10.1371/journal.pone.0142148. eCollection 2015. PLoS One. 2015. PMID: 26544568 Free PMC article.
-
Histology: The gold standard for diagnosis?Can Vet J. 2023 Apr;64(4):389-391. Can Vet J. 2023. PMID: 37008634 Free PMC article. No abstract available.
-
PAX5 gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinoma.Epigenetics. 2017;12(10):865-874. doi: 10.1080/15592294.2017.1365207. Epub 2017 Nov 27. Epigenetics. 2017. PMID: 29099287 Free PMC article.
-
High-risk HPV infection-associated hypermethylated genes in oropharyngeal squamous cell carcinomas.BMC Cancer. 2022 Nov 7;22(1):1146. doi: 10.1186/s12885-022-10227-w. BMC Cancer. 2022. PMID: 36344942 Free PMC article.
-
JAK3 Variant, Immune Signatures, DNA Methylation, and Social Determinants Linked to Survival Racial Disparities in Head and Neck Cancer Patients.Cancer Prev Res (Phila). 2019 Apr;12(4):255-270. doi: 10.1158/1940-6207.CAPR-17-0356. Epub 2019 Feb 18. Cancer Prev Res (Phila). 2019. PMID: 30777857 Free PMC article.
References
-
- Iro H, Waldfahrer F. Evaluation of the newly updated TNM classification of head and neck carcinoma with data from 3247 patients. Cancer. 1998;83(10):2201–2207. - PubMed
-
- Jones AS, Bin Hanafi Z, Nadapalan V, Roland NJ, Kinsella A, Helliwell TR. Do positive resection margins after ablative surgery for head and neck cancer adversely affect prognosis? A study of 352 patients with recurrent carcinoma following radiotherapy treated by salvage surgery. Br J Cancer. 1996;74:128–132. - PMC - PubMed
-
- Koike M, Kodera Y, Itoh Y, et al. Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor. Ann Surg Oncol. 2008;15:1977–1982. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials